ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

トリヘプタノイン

Triheptanoin

HCID 69286
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
620-67-7
標準SMILES
CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
分子式
C24H44O6
平均分子量
428.6 g/mol
単同位体質量
428.31378912

概要

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly. Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of triheptanoin. Triheptanoin was granted FDA approval on 30 June 2020.

名称と識別子

優先名称
Triheptanoin
IUPAC
2,3-di(heptanoyloxy)propyl heptanoate
現地名
トリヘプタノイン
英語名
TRIHEPTANOIN
分子式
C24H44O6
分子量
428.6

名称と別名

Triheptanoin620-67-7TrienanthoinTrioenanthoinTriheptylinGlycerol triheptanoateHeptanoin, tri-Triheptanoic glycerideDermofeel TC 7DojolviGLYCERYL TRIHEPTANOATEglyceroltriheptanoate
名称をさらに表示
1-O,2-O,3-O-トリヘプタノイル-L-グリセロールトリヘプチリン1,2,3-プロパントリイルトリヘプタノアート1,2,3-プロパントリオールトリスヘプタノアート1,2,3-プロパントリイル=トリヘプタノアートトリヘプタン酸1,2,3-プロパントリイルトリヘプタノインミグリオール812トリエナンチンプロパン-1,2,3-トリイル=トリヘプタノアートトリエナント酸グリセロール1,3-ビス(ヘプタノイルオキシ)プロパン-2-イル ヘプタノアートグリセロールトリヘプタノアートC7 oilTRIOENANTHINTRIHEPTANIONtri-heptanoiC7 fatty acid
2,3-di(heptanoyloxy)propyl heptanoateUX007Dub thgDermofeel tc-7Radiamuls 2375Lanol 37 ttriheptanoinatriheptanoine

データベース識別子

CAS

物性

構造計算による物性

XLogP
7.3
極性表面積
78.9 Ų
水素結合供与体数
0
水素結合受容体数
6
回転可能結合数
23
重原子数
30
形式電荷
0
複雑度
421

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
Cosmetics · 2 件

Cosmetic ingredients (Triheptanoin) -> CIR (Cosmetic Ingredient Review)

Skin conditioning; Surfactant

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

物理化学的性質

沸点
200 °C · 200 °C(Press: 1 Torr)
比重(密度)
0.966 g/mL · 0.966 g/mL at 20 °C(lit.)
屈折率
20 · n20/D 1.444
貯蔵温度
-20 °C, · Store at -20°C, protect from light
溶解性
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml
外見
A liquid
色
Colorless to light yellow
安定性
安定。強力な酸化剤とは相容れない。
化粧品成分の機能
皮膚コンディショニング - 閉塞性粘度制御
InChI
InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 62.1% (64 of 103) of all reports.

Warning

H315 (37.9%): Causes skin irritation [Warning Skin corrosion/irritation]

P264, P273, P280, P302+P352, P321, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 103 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information · 3 件

PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.

REACH registered substance: Propane-1,2,3-triyl trisheptanoate (EC: 210-647-2)

Triheptanoin: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesSkin Irrit. 2 (37.9%)

毒性情報

Hepatotoxicity · 1 件

Serum enzyme elevations during triheptanoin therapy are frequent, mostly reflecting the underlying condition of muscle and hepatic accumulation of toxic fatty acid products and lack of adequate energy production. Elevations in CPK were present in 81%, ALT in 72% and AST in 68% of subjects treated in preregistration studies. The elevations were greater than 5 times the upper limit of normal (ULN) of CPK in 47%, ALT in 24% and AST in 15%. Nevertheless, the changes were not considered due to the triheptanoin or MCT therapy but rather to the underlying metabolic disorder and mitochondrial dysfunction. In small trials of triheptanoin in other genetic metabolic diseases, laboratory values were reported to be unchanged during supplementation. Since its approval and more widescale use, there have been no published cases of clinically apparent liver injury attributed to triheptanoin therapy, although its total clinical experience with its use has been limited.

化学と産業

薬理情報

ATC Code · 2 件

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingTriheptanoin is approximately 80% protein bound in plasma, likely serum albumin.
Pharmacodynamics · 1 件

Triheptanoin is a source of medium chain fatty acids for patients with lc-FAODs. It has a moderate duration of action and a wide therapeutic window. Patients should be counselled regarding the risk of feeding tube dysfunction and intestinal malabsorption due to pancreatic insufficiency.

Mechanism of Action · 1 件

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with lc-FAODs treated with triheptanoin experienced improvements in hypoglycemia, cardiomyopathy, and rhabdomyolysis.

Biological Half-LifeDue to multiple peak concentrations of the heptanoate metabolite, the half life of triheptanoin could not be determined.
Metabolism/MetabolitesTriheptanoin is hydrolysed to heptanoate, which can be further metabolized to β-hydroxypentanoate or β-hydroxybutyrate.
FDA Pharmacological Classification · 6 件

2P6O7CFW5K

TRIHEPTANOIN

Established Pharmacologic Class [EPC] - Medium-chain Triglyceride

Chemical Structure [CS] - Triglycerides

Triheptanoin is a Medium-chain Triglyceride.

TRIHEPTANOIN

Absorption, Distribution and Excretion · 3 件

A single 0.3 g/kg dose of triheptanoin reaches a Cmax of 178.9 µmol/L, with a Tmax 0.5 h, and an AUC of 336.5 µmol\*h/L. A single 0.4 g/kg dose of triheptanoin reaches a Cmax of 259.1 µmol/L, with a Tmax 0.8 h, and an AUC of 569.1 µmol\*h/L.

Triheptanoin is minimally eliminated in the urine.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
620-67-7
PubChem CID
69286
DTXSID
DTXSID40862306
ChEMBL
CHEMBL4297585
UNII
2P6O7CFW5K
EC Number
210-647-2
Nikkaji
J53.997J
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
SMILES
C(OC(=O)CCCCCC)C(OC(=O)CCCCCC)COC(=O)CCCCCC
LogP
8.86 at · 8.86 at 22℃
CAS データベース
620 · 620-67-7
EPAの化学物質情報
1 · Heptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester (620-67-7)

化学的性質

化学的特性colourless liquid

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Triheptanoin

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

安全データ

wgk
1
tsca
TSCA listed
rtecs
MB2660000
毒性
LD50 intravenous in mouse: 320mg/kg
risk_code
38
hazard_code
Xi
ストレージクラス
11 - Combustible Solids

A single dose of 0.3 g/kg results in a mean apparent clearance of 6.05 L/h/kg for heptanoate. A single dose of 0.4 g/kg results in a mean apparent clearance of 4.31 L/h/kg for heptanoate.

用途と製造

UsesCIR ingredient: Triheptanoin
Household ProductsInformation on 3 consumer products that contain Triheptanoin in the following categories is provided:
Use ClassificationCosmetics -> Skin conditioning; Surfactant
General Manufacturing InformationHeptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester: ACTIVE

応用分野

使用triheptanoin is a triglyceride that acts as a surfactant and skinconditioning agent, it also helps increase product viscosity. often used in cleansers, face and neck products, moisturizers and lipsticks.

補足説明

定義本品は、ヘプタン酸とグリセリン(*)のトリエステルであり、次の化学式で表される。参照表示名称:グリセリン